Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases

Stem Cells and Development

Volumn 16, Issue 4, 2007, Pages 637-648

  Zhao, Zhi Gang ^a   Liang, Yan ^a   Li, Kai ^a   Li, Wei Ming ^b   Li, Qiu Bai ^b   Chen, Zhi Chao ^b   Zou, Ping ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; CELL SURFACE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; MALE; MESENCHYMAL STEM CELL; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIVISION; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, NON-HODGKIN; MALE; MESENCHYMAL STEM CELLS; PHENOTYPE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34548512229     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0008     Document Type: Article

References (39)

1. Allen TD, TM Dexter and PJ Simmons. (1990). Marrow biology and stem cells. Immunol Ser 49:1-38.
2. Jiang Y, BN Jahagirdar, RL Reinhardt, et al. (2002). Pluripotency of mesenchymal stem cell derived from adult marrow. Nature 418:41-49.
3. Meirelles LS and NB Nardi. (2003). Murine marrow-derived mesenchymal stem cell: Isolation, in vitro expansion, and characterization. Br J Haematol 123:702-711.
4. Koc O and H Lazarus. (2001). Mesenchymal stem cells heading to the clinic. Bone Marrow Transplant 27:235-239.
5. Lazarus HM, SE Haynesworth, SL Gerson, NS Rosenthal and AI Caplan. (1995). Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use. Bone Marrow Transplant 16:557-564.
6. Horwitz EM, DJ Prockop, LA Fitzpatrick, et al. (1999). Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nature Med 5:309-313.
7. Frassoni F, M Labopin and A Bacigalupo. (2002). Expanded mesenchymal stem cells (MSC), co-infused with HLA identical hemopoietic stem cell transplants, reduce acute and chronic graft versus host disease: a matched pair analysis. Bone Marrow Transplant 29(Suppl):S2.
8. Weissman IL. (2000). Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287:1442-1446.
9. Bartholomew A, C Sturgeon, M Siatskas, et al. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48.
10. Tse WT, JD Pendleton, WM Beyer, MC Egalka and EC Guinan. (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 75:389-397.
11. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
12. Krampera M, S Glennie, J Dyson, D Scott, R Laylor, E Simpson and F Dazzi. (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:3722-3729.
13. Majumdar M, M Keane-Moore, D Buyaner, WB Hardy, MA Moorman, KR Mcintosh and JD Mosca. (2003). Characterization and functionality of cell surface molecules on human mesencymal stem cells. J Biomed Sci 10:228-241.
14. Zhang W, W Ge, C Li, S You, L Liao, Q Han, W Deng and RC Zhao. (2004). Effects of mesenchymal stem cells on differentiation,maturation, and function of human monocyte-derived dendritic cells. J Hemtoth Stem Cell 13:263-271.
15. Jiang XX, Y Zhang, B Liu, SX Zhang, Y Wu, XD Yu and N Mao. (2005). Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120-4126.
16. Noort WA, AB Kruisselbrink, PS in't Anker, et al. (2002). Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34 (+) cells in NOD/SCID mice. Exp Hematol 30:870-878.
17. Koc ON, SL Gerson, BW Cooper, SM Dyhouse, SE Haynesworth, AI Caplan and HM Lazarus. (2000). Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18: 307-316.
18. Zhao ZG, XQ Tang, Y You, WM Li, F Liu and P Zou. (2006). Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia. Leuk Res 30:993-1003.
19. Peister A, JA Mellad, BL Larson, BM Hall, LF Gibson and DJ Prockop. (2004). Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103:1662-1668.
20. Yu M, Z Xiao, L Shen and L Li. (2004). Mid-trimester fetal blood-derived adherent cells share characteristics similar to mesenchymal stem cells but full-term umbilical cord blood does not. Br J Haematol 124:666-675.
21. Fukuchi PY, H Nakajima, D Sugiyama, I Hirose, T Kitamura and K Tsuji. (2004). Human placenta-derived cells have mesenchymal stem/progenitor cell. Stem Cells 22:649-658.
22. in't Anker PS, SA Scherjon, CK van der Keur, G de Groot-Swings, F Claas, WE Fibbe and H Kanhai. (2004). Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22:1338-1345.
23. Neame PB, P Soamboonsrup, GP Browman, RM Meyer, A Benger, WE Wilson, IR Walker, N Saeed and JA McBride. (1986). Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML. Blood 68:1355-1362.
24. Federico M, U Vitolo, PL Zinzani, et al. (2000). Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Blood 95:783-789.
25. Sarugaser R, L David, B Dolores, MM Hosseini and JE Davies. (2005). Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 23:220-229.
26. Gupta P, BR Blazar, K Gupta and CM Verfaillie. (1998). Human CD34 bone marrow cells regulate stromal production of interleukin-6 and granulocyte colony-stimulating factor and increase the colony-stimulating activity of stroma. Blood 91:3724-3733.
27. Pittenger MF, AM Mackay, SD Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig, and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
28. Zhao Z, L Liao, Y Cao, X Jiang and CR Zhao. (2005). Establishment and properties of fetal dermis-derived mesenchymal stem cell lines: plasticity in vitro and hematopoietic protection in vivo. Bone marrow transplantation 36:355-365.
29. Dorshkind K. (1990). Regulation of hematopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8:111-137.
30. Majumdar M, M Thiede, S Haynesworth, SP Bruder and SL Gerson. (2001). Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and-support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9:841-848.
31. Majumdar MK, MA Thiede, JD Mosca, M Moorman and M Gerson. (1998). Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176:57-66.
32. Toksoz D, K Zsebo, K Smith, S Hu, D Brankow, SV Suggs, FH Martin and DA Wiliams. (1992). Support of human hematopoiesis in long term bone marrow cultures by murine stromal cells selectively expressing the membrane bound and secreted forms of the human homologue of the steel gene product stem cell factor. Proc Natl Acad Sci USA 89:7350-7354.
33. Bhatia R, PB McGlave, GW Dewald, BR Blazar and CM Verfaillie. (1995). Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. Blood 85:3636-3645.
34. Zhao Y, D Glesne and E Huberman. (2003). A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Nati Acad Sci USA 100:2426-2431.
35. Dilly SA and CJ Jagger. (1990). Bone marrow stromal cell changes in haematological malignancies. J Clin Pathol 43:942-946.
36. Zhang W, G Knieling, G Vohwinkel, T Martinez, R Kuse, DK Hossfeld and U Dulusen. (1999). Origin of stroma cells in long-term bone marrow cultures from patients with acute myeloid leukemia. Ann Hematol 78:305-314.
37. Shin CC, MC Hu, J Hu, J Medeiros and SJ Forman. (1999). Long-term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells. Blood 94:1623-1636.
38. Wetzler M, R Kurzrock, Z Estrov, E Estey and M Talpaz. (1995). Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Leukemia Res 19:23-34.
39. Wetzler M, Z Estrov, M Talpaz, KJ Kim, M Alphonso, R Srinivasan and R Kurzrock. (1994). Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1beta, and TNF-alpha. Cancer Res 54:1837-1842.